UNSPSC 51314384: Acetaminophen/chlorpheniramine/dextromethorphan/phenylpropanolamine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE506. This VA Drug Class (RE506) classifies this compound as belonging to the group ANTIHISTAMINE/DECONGESTANT/ANTITUSSIVE/ANALGESIC.

The first component of this combination drug is an analgesic and antipyretic with the molecular formula C8H9NO2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 362O9ITL9D, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears U.S. National Institutes of Health Compound Identifier 1983. Acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate.

UNSPSC 51314384 Acetaminophen/chlorpheniramine/dextromethorphan/phenylpropanolamine is a Commodity code that does not align with the recent state and local procurement activity tagged under it. The three most recent opportunities—a Seminole County procurement for naloxone and drug deactivation systems, a Texas Health and Human Services Commission RFI on direct-to-manufacturer prescriptions, and a Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) RFP for generic multi-source pharmaceuticals and OTC products—address pharmaceutical procurement, inventory management, and distribution logistics at scale, but none specifically target the acetaminophen combination product referenced in the code's nominal scope. The Seminole County and MMCAP solicitations both involve bulk supply agreements for state and local health and human services delivery, while the Texas HHS RFI explores alternative contracting models with manufacturers outside traditional pharmacy benefit manager and wholesaler channels.

Recent activity shows issuing bodies spanning county health departments (Seminole County, Florida), state health and human services commissions (Texas HHS), and multistate cooperative purchasing vehicles (MMCAP, administered by Minnesota Department of Administration with participating states including Oregon). The Seminole County IFB (Solicitation IFB60459723LAS, due July 26, 2023) sought 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly delivery to the Seminole County Community Health Building in Sanford, Florida. The MMCAP RFP (Solicitation S1070000015802, due March 26, 2026) established multiple contracts for generic multi-source pharmaceuticals and OTC products across participating state and local facilities, with awarded vendors effective July 1, 2026, and contract pricing evaluated on competitiveness (75 percent weight) and compliance with administrative and regulatory requirements. The code shows little recent relevant activity aligned with its stated pharmaceutical combination product profile.